The Therapeutic Goods Administration (TGA) has approved the use of the first treatment in Australia for geographic atrophy (GA) — a disease which causes severe, progressive central vision loss and is ...

Marci English, vice president, head of biopharma and ophthalmology development, Astellas, said: “Today’s submission comes as good news to people in Japan living with geographic atrophy who have no ...

Astellas said the Ministry of Health, Labour and Welfare will evaluate ACP as a potential first treatment for patients with geographic atrophy. The company will also evaluate secondary to age ...

Ministry of Health, Labour and Welfare to evaluate ACP as potential first and only treatment for patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD ...

Learn more at www.astellas.com. 3 Colijn JM, Liefers B, Joachim N, et al. Enlargement of geographic atrophy from first diagnosis to end of life. JAMA Ophthalmol. 2021;139(7):743–750.

Learn more at www.astellas.com. 3 Colijn JM, Liefers B, Joachim N, et al. Enlargement of geographic atrophy from first diagnosis to end of life. JAMA Ophthalmol. 2021;139(7):743–750. 4 Lundeen EA, ...

Ministry of Health, Labour and Welfare to evaluate ACP as potential first and only treatment for patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in Japan- ...

Two novel reading speed metrics may better indicate functional decline in geographic atrophy than 2 more commonly-used methods. In patients with geographic atrophy secondary to age-related macular ...

Goldberg, MD, MBA, discusses the role of multimodal imaging in geographic atrophy in the era of complement inhibitors. Imaging confirms the correct diagnosis, identifies which patients will be the ...